In 2017, the Pancreatic Cancer Action Network (PanCAN) awarded six new grants to advance novel treatment options for patients with pancreatic cancer, including two first-time precision medicine targeted grants.
These grants were part of the 17 total 2017 research grants PanCAN recently awarded to 21 researchers at 12 institutions across the country. Read more . . .